PO.1.1 Afimetoran, a potent and selective inhibitor of human toll-like receptor 7 (TLR7) and tlr8, provides robust efficacy in a murine lupus model of advanced disease by A Rudra, H Qiu, R Zhang, S Dudhgaonkar, S Ranade, S Subramani, J Nagar, P Karunanithi, P Bhutani, V Kurawattimath, A Dyckman, G Schieven